Download PDF
Semin Liver Dis 2009; 29(3): 331-334
DOI: 10.1055/s-0029-1233537
DIAGNOSTIC PROBLEMS IN HEPATOLOGY

© Thieme Medical Publishers

Vaccination as a Triggering Event for Autoimmune Hepatitis

Ponni Perumalswami1 , Lan Peng2 , Joseph A. Odin1
  • 1Division of Liver Diseases, Department of Medicine, The Mount Sinai Medical Center, New York, New York
  • 2Division of Liver Pathology, The Lillian and Henry M. Stratton-Hans Popper Department of Pathology, The Mount Sinai Medical Center, New York, New York
Further Information

Publication History

Publication Date:
12 August 2009 (online)

    Permissions and Reprints

ABSTRACT

The pathogenesis of autoimmune hepatitis entails complex interactions between triggering factors, autoantigens, genetic predisposition, and immunoregulatory networks. Implicated triggering factors are numerous and include toxins, medications, and infectious agents. In this article, we present a unique case of a 31-year-old woman with severe autoimmune hepatitis apparently abruptly triggered by vaccination. All evidence suggests this was an idiosyncratic response to either hepatitis A or yellow fever vaccination.

KEYWORDS

Autoimmune hepatitis - vaccination - yellow fever - hepatitis A

REFERENCES

  • 1 Hennes E M, Zeniya M, Czaja A J et al.. Simplified criteria for the diagnosis of autoimmune hepatitis.  Hepatology. 2008;  48(1) 169-176
    CrossrefPubMedGoogle Scholar
  • 2 Czaja A J. Autoimmune hepatitis. Evolving concepts and treatment strategies.  Dig Dis Sci. 1995;  40(2) 435-456
    CrossrefPubMedGoogle Scholar
  • 3 Czaja A J, Carpenter H A. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis.  Gastroenterology. 1993;  105(6) 1824-1832
    PubMedGoogle Scholar
  • 4 Czaja A J, Donaldson P T. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis.  Immunol Rev. 2000;  174 250-259
    CrossrefPubMedGoogle Scholar
  • 5 Czaja A J. Understanding the pathogenesis of autoimmune hepatitis.  Am J Gastroenterol. 2001;  96(4) 1224-1231
    CrossrefPubMedGoogle Scholar
  • 6 Vento S, Guella L, Mirandola F et al.. Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals.  Lancet. 1995;  346(8975) 608-609
    CrossrefPubMedGoogle Scholar
  • 7 Medina J, García-Buey L, Moreno-Otero R. Review article: immunopathogenetic and therapeutic aspects of autoimmune hepatitis.  Aliment Pharmacol Ther. 2003;  17(1) 1-16
    PubMedGoogle Scholar
  • 8 Huppertz H I, Treichel U, Gassel A M, Jeschke R, Meyer zum Büschenfelde K H. Autoimmune hepatitis following hepatitis A virus infection.  J Hepatol. 1995;  23(2) 204-208
    CrossrefPubMedGoogle Scholar
  • 9 Skoog S M, Rivard R E, Batts K P, Smith C I. Autoimmune hepatitis preceded by acute hepatitis A infection.  Am J Gastroenterol. 2002;  97(6) 1568-1569
    CrossrefPubMedGoogle Scholar
  • 10 Veerappan G R, Mulhall B P, Holtzmuller K C. Vaccination-induced autoimmune hepatitis.  Dig Dis Sci. 2005;  50(1) 212-213
    CrossrefPubMedGoogle Scholar
  • 11 Bogdanos D P, Invernizzi P, Mackay I R, Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges.  World J Gastroenterol. 2008;  14(21) 3374-3387
    CrossrefPubMedGoogle Scholar

Joseph A OdinM.D. Ph.D. 

Division of Liver Diseases, Box 1101

The Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029

Email: Joseph.Odin@msnyuhealth.org

      >